Page last updated: 2024-09-05

dabigatran and ximelagatran

dabigatran has been researched along with ximelagatran in 30 studies

Compound Research Comparison

Studies (dabigatran)	Trials (dabigatran)	Recent Studies (post-2010) (dabigatran)	Studies (ximelagatran)	Trials (ximelagatran)	Recent Studies (post-2010) (ximelagatran)
3,887	261	3,490	399	75	42

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (30.00)	29.6817
2010's	21 (70.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fischer, PM	1
Gustafsson, D	1
Bates, SM; Weitz, JI	1
Ma, Q	1
Eikelboom, JW; Hirsh, J; O'Donnell, M	1
Harenberg, J; Wehling, M	1
Brotman, DJ; Jaffer, AK	1
Lucas, J; Marco, P; Tarín, F	1
Halperin, JL	1
Argyle, RA; Lomas, O; Prendergast, BD	1
Banda, ZK; Benmira, S; Bhattacharya, V	1
Malaga, G; Malasquez, G; Salazar, CA	1
Christersson, C; Johnell, M; Siegbahn, A	1
Lowenthal, DT; Sattari, M	1
Lane, DA; Lip, GY	1
Baumhäkel, M; Böhm, M; Schirmer, SH	1
Vivancos Mora, J; Ximénez-Carrillo Rico, A; Zapata Wainberg, G	1
Brenner, B; Hoffman, R	1
Fernández, D; Heras, M; Penela, D	1
Badimón, JJ; Briongos Figuero, S; García Santos-Gallego, C	1
Artang, R; Nielsen, JD; Rome, E; Vidaillet, HJ	1
Bassand, JP	1
Cordova, EG; del Aguila, D; Salazar, CA	1
Akl, EA; Barba, M; Kahale, L; Labedi, N; Muti, P; Neumann, I; Schünemann, H; Sperati, F; Terrenato, I	1
Kesteven, P; McCaslin, JE; Robertson, L	1
Crawford, B; Morimoto, T; Ueda, S; Wada, K	1
Chu, XC; Gao, JH; Ning, B; Wang, LL; Zhao, CX	1
Akl, EA; Barba, M; Hakoum, MB; Kahale, LA; Matar, CF; Schünemann, H; Sperati, F; Terrenato, I; Tsolakian, IG; Yosuico, VE	1
Wallentin, L	1

Reviews

26 review(s) available for dabigatran and ximelagatran

Article	Year
Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs. Journal of medicinal chemistry, 2018, 05-10, Volume: 61, Issue:9 Topics: Amino Acid Sequence; Animals; Anticoagulants; Blood Coagulation; Catalytic Domain; Humans; Peptide Hydrolases; Protease Inhibitors; Small Molecule Libraries	2018
Oral direct thrombin inhibitors in clinical development. Journal of internal medicine, 2003, Volume: 254, Issue:4 Topics: Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Glycine; Hemostasis; Humans; Prodrugs; Pyridines; Stroke; Thrombin; Thrombosis; Venous Thrombosis; Vitamin K	2003
Preparing for the post-warfarin generation of antithrombotics. The American journal of managed care, 2004, Volume: 10, Issue:10 Suppl Topics: Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clopidogrel; Fibrinolytic Agents; Fondaparinux; Humans; Oligosaccharides; Platelet Aggregation Inhibitors; Polysaccharides; Prodrugs; Pyridines; Stroke; Ticlopidine	2004
New anticoagulants. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:8 Topics: Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Blood Coagulation; Blood Coagulation Factors; Dabigatran; Factor IX; Fibrinolytic Agents; Humans; Models, Biological; Protein C; Pyridines; Thrombin; Thromboembolism; Venous Thrombosis	2005
Beyond unfractionated heparin and warfarin: current and future advances. Circulation, 2007, Jul-31, Volume: 116, Issue:5 Topics: Angina, Unstable; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Brain Ischemia; Clinical Trials as Topic; Coumarins; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Forecasting; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Morpholines; Myocardial Infarction; Peptide Fragments; Polysaccharides; Prothrombin; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Thrombosis; Warfarin	2007
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Seminars in thrombosis and hemostasis, 2008, Volume: 34, Issue:1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Glycine; Humans; Infusions, Parenteral; Morpholines; Oligosaccharides; Piperazines; Prothrombin; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Venous Thromboembolism	2008
Prevention of venous thromboembolism in the geriatric patient. Cardiology clinics, 2008, Volume: 26, Issue:2 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Elective Surgical Procedures; Fibrinolytic Agents; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Polysaccharides; Prodrugs; Pyridines; Risk Factors; Vena Cava Filters; Venous Thromboembolism	2008
[New oral anticoagulants: molecular characteristics, mechanisms of action, pharmacokinetics and pharmacodynamics]. Medicina clinica, 2008, Volume: 131 Suppl 2 Topics: Administration, Oral; Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dabigatran; Disease Models, Animal; Factor Xa Inhibitors; Forecasting; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Pyridines; Quality of Life; Thrombin; Time Factors	2008
What can ongoing clinical trials of anticoagulants demonstrate? Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:8 Topics: Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Drugs, Investigational; Humans; Oligosaccharides; Pyridines; Thromboembolism; United States	2009
Old versus new anticoagulants: focus on pharmacology. Recent patents on cardiovascular drug discovery, 2010, Volume: 5, Issue:2 Topics: Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Oligosaccharides; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Warfarin	2010
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. The Cochrane database of systematic reviews, 2010, Apr-14, Issue:4 Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Azetidines; Benzimidazoles; Benzylamines; Contraindications; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Pyridines; Randomized Controlled Trials as Topic; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin	2010
Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Drug Approval; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; United States; Venous Thrombosis	2011
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? The American journal of medicine, 2010, Volume: 123, Issue:9 Topics: Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Biphenyl Compounds; Dabigatran; Humans; Irbesartan; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Stroke; Tetrazoles; Warfarin	2010
[Novel anticoagulants for stroke prevention in atrial fibrillation]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:46 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism	2010
[Clinical management of the new anticoagulants]. Neurologia (Barcelona, Spain), 2012, Volume: 27 Suppl 1 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Monitoring; Drugs, Investigational; Hemorrhage; Humans; Morpholines; Multicenter Studies as Topic; Patient Care Planning; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombophilia; Vitamin K	2012
The promise of novel direct oral anticoagulants. Best practice & research. Clinical haematology, 2012, Volume: 25, Issue:3 Topics: Anticoagulants; Antithrombins; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Thromboembolism; Warfarin	2012
[Contribution of the new oral anticoagulants to the treatment of acute coronary syndrome]. Medicina clinica, 2012, Volume: 139 Suppl 2 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Azepines; Azetidines; Benzamides; Benzimidazoles; Benzylamines; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes	2012
[Improvements in oral anticoagulant therapy for atrial fibrillation]. Medicina clinica, 2013, Dec-07, Volume: 141, Issue:11 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Embolism; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Treatment Outcome; Warfarin	2013
Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors. The American journal of cardiology, 2013, Dec-15, Volume: 112, Issue:12 Topics: Amidines; Anticoagulants; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Warfarin	2013
Novel oral anticoagulants in acute coronary syndrome: re-evaluating the thrombin hypothesis. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Mar-20, Volume: 9, Issue:11 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Azepines; Azetidines; Benzamides; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Vitamin K	2014
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation. The Cochrane database of systematic reviews, 2014, Mar-27, Issue:3 Topics: Amidines; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Drug Administration Schedule; Embolism; Female; Humans; Male; Randomized Controlled Trials as Topic; Safety-Based Drug Withdrawals; Stroke; Vitamin K; Warfarin	2014
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. The Cochrane database of systematic reviews, 2014, Jul-08, Issue:7 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Oligosaccharides; Randomized Controlled Trials as Topic; Venous Thromboembolism; Vitamin K	2014
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. The Cochrane database of systematic reviews, 2015, Jun-30, Issue:6 Topics: Administration, Oral; Antithrombins; Azetidines; Benzylamines; Dabigatran; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thrombosis	2015
Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies. Journal of cardiology, 2015, Volume: 66, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Odds Ratio; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2015
Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis. Medicine, 2017, Volume: 96, Issue:40 Topics: Anticoagulants; Arthroplasty; Azetidines; Benzylamines; Dabigatran; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Humans; Network Meta-Analysis; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism; Warfarin	2017
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. The Cochrane database of systematic reviews, 2018, 06-19, Volume: 6 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Oligosaccharides; Randomized Controlled Trials as Topic; Venous Thromboembolism; Vitamin K	2018

Other Studies

4 other study(ies) available for dabigatran and ximelagatran

Article	Year
Development of oral anticoagulants. British journal of clinical pharmacology, 2007, Volume: 64, Issue:3 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Drug Delivery Systems; Drug Design; Enoxaparin; Factor Xa Inhibitors; Humans; Morpholines; Postoperative Hemorrhage; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin	2007
Will direct thrombin inhibition change the boundaries of oral anti-coagulation? QJM : monthly journal of the Association of Physicians, 2010, Volume: 103, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Blood Coagulation; Dabigatran; Humans; Pyridines; Thrombin; Venous Thromboembolism	2010
The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression. Thrombosis research, 2010, Volume: 126, Issue:4 Topics: Antithrombins; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Blood Platelets; Cell-Derived Microparticles; Dabigatran; Gene Expression; Humans; Leukocytes; Myocardial Infarction; Platelet Activation; Platelet Aggregation; RNA, Messenger; Thromboplastin	2010
Lakartidningen, 2018, 12-04, Volume: 115 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Azetidines; Benzylamines; Dabigatran; Factor Xa Inhibitors; Humans; Safety-Based Drug Withdrawals; Stroke; Warfarin	2018